{"nct_id":"NCT00050440","title":"Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma","status":"COMPLETED","status_verified_date":"2013-01","start_date":"2002-07","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2004-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}